Research to elucidate the anti-tumor immune responses and develop the combination therapy in solid tumor
Not Applicable
- Conditions
- Solid tumor
- Registration Number
- JPRN-UMIN000040280
- Lead Sponsor
- Osaka International Cancer Institute, Research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
The cases an attending physician determined ineligible.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analysis of tumor cells and immune cells in tumor microenvironment and peripheral blood.
- Secondary Outcome Measures
Name Time Method